↓ Skip to main content

Disruptive Psychopharmacology

Overview of attention for book
Cover of 'Disruptive Psychopharmacology'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 266 Foundations for Training Psychedelic Therapists.
  3. Altmetric Badge
    Chapter 267 Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms
  4. Altmetric Badge
    Chapter 268 Psychedelic Group Therapy
  5. Altmetric Badge
    Chapter 269 Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults
  6. Altmetric Badge
    Chapter 270 Dosing Psychedelics and MDMA
  7. Altmetric Badge
    Chapter 277 Ayahuasca for the Treatment of Depression
  8. Altmetric Badge
    Chapter 278 The Potential of Psychedelics for End of Life and Palliative Care
  9. Altmetric Badge
    Chapter 279 Psilocybin for the Treatment of Obsessive-Compulsive Disorders
  10. Altmetric Badge
    Chapter 282 Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach
  11. Altmetric Badge
    Chapter 284 Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.
  12. Altmetric Badge
    Chapter 298 Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature
  13. Altmetric Badge
    Chapter 313 Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics
  14. Altmetric Badge
    Chapter 327 Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation
  15. Altmetric Badge
    Chapter 365 Psychedelics in the Treatment of Headache and Chronic Pain Disorders
  16. Altmetric Badge
    Chapter 366 Psilocybin for Trauma-Related Disorders
  17. Altmetric Badge
    Chapter 367 Psychedelics and Anti-inflammatory Activity in Animal Models
Attention for Chapter 278: The Potential of Psychedelics for End of Life and Palliative Care
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 514)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
30 news outlets
blogs
1 blog
twitter
45 X users

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Potential of Psychedelics for End of Life and Palliative Care
Chapter number 278
Book title
Disruptive Psychopharmacology
Published in
Current topics in behavioral neurosciences, January 2021
DOI 10.1007/7854_2021_278
Pubmed ID
Book ISBNs
978-3-03-112183-8, 978-3-03-112184-5
Authors

Yaden, David B., Nayak, Sandeep M., Gukasyan, Natalie, Anderson, Brian T., Griffiths, Roland R., Yaden, David B, Nayak, Sandeep M, Anderson, Brian T, Griffiths, Roland R, David B Yaden, Sandeep M Nayak, Natalie Gukasyan, Brian T Anderson, Roland R Griffiths

Abstract

End of life and palliative care has improved in recent decades but the psychopharmacological options available to clinicians and patients in these contexts remain limited. In particular, psychological factors such as depression, existential distress, and well-being remain challenging to address with current medications. Here, we review recent research on the use of psychedelics in clinical settings with a particular focus on patients with life-threatening diagnoses. We propose that psychedelics may provide clinicians with an additional psychopharmacological treatment in the context of end of life and palliative care.

X Demographics

X Demographics

The data shown below were collected from the profiles of 45 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 20%
Other 3 7%
Student > Doctoral Student 3 7%
Student > Ph. D. Student 3 7%
Researcher 3 7%
Other 6 13%
Unknown 19 41%
Readers by discipline Count As %
Psychology 9 20%
Medicine and Dentistry 5 11%
Nursing and Health Professions 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Social Sciences 2 4%
Other 5 11%
Unknown 21 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 274. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2023.
All research outputs
#132,118
of 25,563,770 outputs
Outputs from Current topics in behavioral neurosciences
#3
of 514 outputs
Outputs of similar age
#3,836
of 523,214 outputs
Outputs of similar age from Current topics in behavioral neurosciences
#1
of 15 outputs
Altmetric has tracked 25,563,770 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 514 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 523,214 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.